February 27, 2020 / 9:23 PM / a month ago

BRIEF-Cara Therapeutics Reports Q4 Loss Per Share $0.61

Feb 27 (Reuters) - Cara Therapeutics Inc:

* CARA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.61

* Q4 EARNINGS PER SHARE ESTIMATE $-0.66 — REFINITIV IBES DATA

* EXPECTS TOP-LINE DATA FOR ITS PIVOTAL KALM-2 PHASE 3 GLOBAL TRIAL OF KORSUVA INJECTION IN Q2 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below